Full text

Turn on search term navigation

© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.

Abstract

Multimodality imaging is a comprehensive strategy to investigate left ventricular hypertrophy (LVH), providing morphologic, functional, and often clinical information to clinicians. Hypertrophic cardiomyopathy (HCM) is defined by an increased LV wall thickness not only explainable by abnormal loading conditions. In the context of HCM, multimodality imaging, by different imaging techniques, such as echocardiography, cardiac magnetic resonance, cardiac computer tomography, and cardiac nuclear imaging, provides essential information for diagnosis, sudden cardiac death stratification, and management. Furthermore, it is essential to uncover the specific cause of HCM, such as Fabry disease and cardiac amyloidosis, which can benefit of specific treatments. This review aims to elucidate the current role of multimodality imaging in adult patients with HCM.

Details

Title
Multimodality Imaging in Cardiomyopathies with Hypertrophic Phenotypes
Author
Monda, Emanuele 1   VIAFID ORCID Logo  ; Palmiero, Giuseppe 1   VIAFID ORCID Logo  ; Lioncino, Michele 1 ; Rubino, Marta 1 ; Cirillo, Annapaola 1 ; Fusco, Adelaide 1 ; Caiazza, Martina 1   VIAFID ORCID Logo  ; Verrillo, Federica 1 ; Gaetano, Diana 1 ; Mauriello, Alfredo 1 ; Iavarone, Michele 1 ; Losi, Maria Angela 2 ; De Rimini, Maria Luisa 3 ; Santo Dellegrottaglie 4   VIAFID ORCID Logo  ; Antonello D’Andrea 5   VIAFID ORCID Logo  ; Bossone, Eduardo 6   VIAFID ORCID Logo  ; Pacileo, Giuseppe 1 ; Limongelli, Giuseppe 1   VIAFID ORCID Logo 

 Inherited and Rare Cardiovascular Diseases, Department of Translational Medical Sciences, University of Campania “Luigi Vanvitelli”, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy; [email protected] (E.M.); [email protected] (G.P.); [email protected] (M.L.); [email protected] (M.R.); [email protected] (A.C.); [email protected] (A.F.); [email protected] (M.C.); [email protected] (F.V.); [email protected] (G.D.); [email protected] (A.M.); [email protected] (M.I.); [email protected] (G.P.) 
 Department of Advanced Biomedical Sciences, Federico II University of Naples, 80138 Naples, Italy; [email protected] 
 Department of Nuclear Medicine, AORN Ospedali dei Colli-Monaldi Hospital, 80131 Naples, Italy; [email protected] 
 Cardiovascular MRI Laboratory, Division of Cardiology, Ospedale Medico-Chirurgico Accreditato Villa dei Fiori, 80011 Acerra, Italy; [email protected] 
 Unit of Cardiology and Intensive Coronary Care, “Umberto I” Hospital, 84014 Nocera Inferiore, Italy; [email protected] 
 Department of Cardiology, Cardarelli Hospital, 80131 Naples, Italy; [email protected] 
First page
868
Publication year
2022
Publication date
2022
Publisher
MDPI AG
e-ISSN
20770383
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2627601837
Copyright
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.